The FDA also approved Repatha as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia (HoFH) for younger pediatric patients
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
SPARC enters definitive agreement to monetise rare paediatric disease PRV, unlocking capital for R&D and strategic growth
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists
Subscribe To Our Newsletter & Stay Updated
